Nicardipine
Dihydropyridine Derivatives
- Drug class
- Dihydropyridine Derivatives
- Availability
- Prescription only
- Routes
- Intravenous, Oral
- Markets covered
- 2
- Products on record
- 8
Overview
Plain-language summary, compiled from the cited regulatory records
Nicardipine is a medication belonging to the dihydropyridine derivative class of drugs [1]. It is approved for managing patients with chronic stable angina, also known as effort-associated angina [1]. In these cases, nicardipine hydrochloride capsules can be used as a standalone treatment or in conjunction with beta-blockers [1].
Additionally, nicardipine hydrochloride capsules are indicated for the treatment of hypertension, or high blood pressure [1]. It may be prescribed alone or combined with other antihypertensive medications [1].
Nicardipine is available under various brand names.
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 5 | May 15, 2026 |
| US United States | FDA | 3 | August 24, 2024 |
GBUnited Kingdom· MHRA
5 products
Uses
The prophylaxis of patients with chronic stable angina, and the treatment of mild to moderate hypertension.
How to take
USUnited States· FDA
3 products
Uses
1 INDICATIONS AND USAGE Nicardipine hydrochloride injection, USP is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible. 1 Hypertension Nicardipine hydrochloride injection, USP is indicated for the short-term treatment of hypertension when oral therapy is not feasible or desirable.
6) ].
How to take
Drug interactions
Known interactions involving Nicardipine. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 414. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL113110101 · revised May 15, 2026
- [2]FDA DailyMed · 18fb1c2b-0c1e-43… · revised August 24, 2024 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.